Sihuan Pharmaceutical Holdings Group Ltd
Company Profile
Business description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
Contact
Zhubang 2000
22nd Floor, Building 4
West Balizhuang, Chaoyang District
Beijing100025
CHNT: +86 1057693700
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
2,667
Stocks News & Analysis
stocks
ResMed earnings: Solid showing from ASX healthcare winner
stocks
Is this the $80 billion elephant Warren Buffett has been waiting for?
stocks
Tesla: Board announces new pay package for CEO Elon Musk
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,028.80 | 106.80 | 1.20% |
CAC 40 | 7,650.18 | 18.17 | 0.24% |
DAX 40 | 23,854.46 | 96.77 | 0.41% |
Dow JONES (US) | 44,173.64 | 42.66 | 0.10% |
FTSE 100 | 9,152.78 | 24.48 | 0.27% |
HKSE | 24,873.28 | 139.83 | 0.57% |
NASDAQ | 21,053.58 | 403.45 | 1.95% |
Nikkei 225 | 40,549.54 | 258.84 | 0.64% |
NZX 50 Index | 12,877.04 | 193.00 | 1.52% |
S&P 500 | 6,329.94 | 91.93 | 1.47% |
S&P/ASX 200 | 8,770.40 | 106.70 | 1.23% |
SSE Composite Index | 3,617.60 | 34.29 | 0.96% |